Where I see patients (2)
My reviews
Selected research
-
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.
medRxiv : the preprint server for health sciences
-
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network : JNCCN
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 885-3882
5.0